Future Fertility
Future Fertility
Future Fertility develops clinically validated, AI-powered, non-invasive tools that assess oocyte (egg) quality from laboratory images. The company's mission is to provide objective, reproducible oocyte quality insights that help patients, clinics, and egg banks make more informed fertility and treatment decisions.
Products and services
Future Fertility offers patient-facing reports and clinical tools that deliver personalized egg quality information. Key offerings include VIOLET™ for egg freezing, MAGENTA™ for IVF, and ROSE™ for donor egg programs. These products integrate with existing lab workflows and provide actionable quality scores and reports.
- For Clinics: objective oocyte quality data to improve counselling and tailor treatment plans
- For Patients: personalized reports to understand individual egg quality and support decision making
- For Egg Banks: tools to optimize oocyte distribution based on objective quality metrics
Clinical validation, reach & recognition
The company partners with leading fertility clinics to validate its AI models, with results published in peer-reviewed journals and presented in many abstracts. Future Fertility reports that its assessments are used in over 300 clinics across 35+ countries and that its egg quality reports have received industry awards for innovation and product quality.